(Q79078013)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14505047%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

Phase 2 trial of pegylated liposomal doxorubicin in advanced endometrial cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14505047%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

main subject

phase II clinical trial

1 reference

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1007/S00432-003-0497-8

13 March 2024

author name string

Maurie Markman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14505047%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Kristine Zanotti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14505047%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Kenneth Webster

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14505047%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Jerome Belinson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14505047%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Pedro F. Escobar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14505047

13 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14505047

13 March 2024

publication date

23 September 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14505047%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 December 2019

http://link.springer.com/content/pdf/10.1007/s00432-003-0497-8.pdf

file format

Portable Document Format

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1007/S00432-003-0497-8

http://link.springer.com/article/10.1007/s00432-003-0497-8/fulltext.html

13 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00432-003-0497-8

http://link.springer.com/content/pdf/10.1007/s00432-003-0497-8

13 March 2024

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1007/S00432-003-0497-8

Journal of Cancer Research and Clinical Oncology

13 March 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14505047%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14505047%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14505047%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

651-654

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14505047%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00432-003-0497-8

19 December 2019

exact match

0 references

cites work

A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group study

1 reference

12 December 2020

Phase II trial of the pegylated liposomal doxorubicin in previously treated metastatic endometrial cancer: a Gynecologic Oncology Group study

1 reference

12 December 2020

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

1 reference

12 December 2020

Phase 2 trial of liposomal doxorubicin (40 mg/m(2)) in platinum/paclitaxel-refractory ovarian and fallopian tube cancers and primary carcinoma of the peritoneum

1 reference

12 December 2020

Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.

1 reference

12 December 2020

CA 125: a useful marker in endometrial carcinoma

1 reference

12 December 2020

Liposomal doxorubicin in ovarian, peritoneal, and tubal carcinoma: a retrospective comparative study of single-agent dosages.

1 reference

12 December 2020

The clinical utility of liposomal doxorubicin in recurrent ovarian cancer

1 reference

12 December 2020

Endometrial carcinoma

1 reference

12 December 2020

Systemic treatment of advanced and recurrent endometrial carcinoma: current status and future directions

1 reference

12 December 2020

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14505047%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference